Recruiting
B-cell type acute leukaemia
RecruitingStudy on CD19-CAR T Cells, Fludarabine, and Cyclophosphamide for Children and Young Adults with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Registered drugNo placebo
Study on CD19-CAR T Cells, Fludarabine, and Cyclophosphamide for Children and Young Adults with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Registered drugNo placebo
- Disease:B-cell type acute leukaemia
- Substances:Cd19-Car_Lenti_AlloCyclophosphamide+1
Countries:
Italy
Italy- Participants:0–17 years · 18–64 years
- Substances:Cd19-Car_Lenti_Allo
